P
Paul Elliott
Researcher at Imperial College London
Publications - 858
Citations - 123179
Paul Elliott is an academic researcher from Imperial College London. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 153, co-authored 773 publications receiving 103839 citations. Previous affiliations of Paul Elliott include Health Protection Agency & University of Huddersfield.
Papers
More filters
Journal ArticleDOI
Effect of ultraprocessed food intake on cardiometabolic risk is mediated by diet quality: a cross-sectional study
TL;DR: In this article, the authors examined the effect of the consumption of ultraprocessed food on diet quality, and cardiometabolic risk in an occupational cohort in a British police force.
Journal ArticleDOI
Trends in stroke mortality in Greater London and south east England--evidence for a cohort effect?
TL;DR: There seems to be a cohort effect on stroke mortality which is not explained by past maternal and neonatal mortality, and the Health of the Nation stroke target is unlikely to be achieved in Greater London.
Posted ContentDOI
Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
Oliver Eales,Kylie E. C. Ainslie,Caroline E. Walters,Haowei Wang,Christina Atchison,Deborah Ashby,Christl A. Donnelly,Graham S Cooke,Wendy S. Barclay,Helen Marie Ward,Ara Darzi,Paul Elliott,Steven Riley +12 more
TL;DR: The authors developed a Bayesian P-spline model suitable fitting to a wide range of epidemic time-series, including daily point-series data in the CoV-ence model.
Journal ArticleDOI
Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings
Aikaterini Iliou,Emmanuel Mikros,Ibrahim Karaman,Freya Elliott,Julian L. Griffin,Ioanna Tzoulaki,Paul Elliott +6 more
TL;DR: In this paper, the main methodologies for metabolic phenotyping, the methodological steps to analyse these data in epidemiological settings and the associated challenges are discussed, as well as evidence from epidemiological studies linking metabolites to coronary heart disease and stroke.